Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · August 28, 2023

Determinants of Survival in Patients With HER2+ Metastatic Esophagogastric Cancer

Clinical Cancer Research


Additional Info

Clinical Cancer Research
Determinants of survival in HER2+ metastatic esophagogastric cancer
Clin. Cancer Res 2023 Jul 05;[EPub Ahead of Print], SB Maron, W Chatila, H Walch, JF Chou, N Ceglia, R Ptashkin, RKG Do, V Paroder, N Pandit-Taskar, JS Lewis, T Biachi De Castria, S Sabwa, F Socolow, L Feder, J Thomas, I Schulze, K Kim, A Elzein, V Bojilova, M Zatzman, U Bhanot, RJ Nagy, J Lee, M Simmons, M Segal, GY Ku, DH Ilson, M Capanu, JF Hechtman, T Merghoub, S Shah, N Schultz, DB Solit, YY Janjigian

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading